EVERSANA Unveils Global Market Access Research Solution
EVERSANA-independent provider of global services for the life sciences industry-released Global Market Access Insights, a new suite of global market access solutions from Health Strategies Insights for biopharma manufacturers. The suite helps manufacturers understand the latest global trends in access, payment, distribution, and administration.
Global Market Access Insights includes:
- Frameworks and proprietary methods.
- Access to a panel of industry experts.
- Address payer stakeholders’ challenges through Global Access Express, which deploys custom research studies to EU5 stakeholders and returns insights within 10 business days.
- Insights on the impact of Evolution of the Global Biosimilars Market and how these blockbuster therapies are evolving in key geographies, including the U.S.
- U.S. Knowledge for Global Market Access to help inform global market access strategies.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
